Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
WuXi AppTec announced the company's Wuhan site has resumed operations, in compliance with local regulations and global COVID-19 health and safety guidelines.
read more
Tuesday, January 20, 2026
WuXi AppTec announced that it has been recognized on the "A List" for leadership in corporate transparency and performance across both Climate Change and Water Security by CDP (Carbon Disclosure Project). This recognition, which represents CDP's ...
read more
WuXi AppTec Co. Ltd. has started construction of a state-of-the-art integrated biologics solution center at the company's headquarters in Shanghai. The company plans to invest a total of $120 million in this dedicated, 250,000-square-foot facility, ...
read more
WuXi AppTec (WuXi), recently opened their new 150,000-square-foot biomanufacturing facility in an event attended by Pennsylvania Lieutenant Governor Mike Stack and WuXi AppTec Chairman and Chief Executive Officer, Dr. Ge Li. The new facility is WuXi...
read more
WuXi AppTec an open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology and medical device industries, has announced the opening of its branch office in Seoul, South Korea.
read more
Monday, September 09, 2019
WuXi AppTec announced its launch of a novel DNA Encoded Library service package, providing efficient hit finding services to expedite early drug discovery and bring new medicines to patients faster.
read more
WuXi AppTec an open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology and medical device industries, has announced that WuXi Lab Testing Division (LTD)'s late-and commercial-stage analytical and ...
read more
WuXi AppTec hosted an inaugural Global Monoclonal Antibody Summit in conjunction with the startup of its cGMP biologics manufacturing facility in the city of Wuxi on October 10-12, 2012. Attending the event were executives from global pharmaceutical ...
read more
Wednesday, April 25, 2018
WuXi AppTec announced the opening of its expanded Laboratory Testing Division facility in New Jersey.
read more
Monday, December 10, 2018
WuXi AppTec announces the expansion of its facilities in San Diego, California.
read more
Thursday, October 30, 2025
WuXi AppTec has reached a definitive agreement to sell its China-based clinical research services subsidiaries, WuXi Clinical and WuXi MedKey, to Hillhouse Investment Management, a global private asset manager.
read more
Wednesday, March 03, 2021
WuXi AppTec has completed the acquisition of OXGENE, a UK-based contract research and development organization that designs and develops scalable gene therapy technologies.
read more
WuXi AppTec announced it has acquired Pharmapace, a US-based clinical research services company with expertise of providing high quality biometrics services.
read more
WuXi AppTec, a global pharmaceutical, biotechnology and medical device open-access capability and technology platform, has acquired HD Biosciences (HDB), a biology focused preclinical drug discovery contract research organization (CRO).
read more
WuXi AppTec, an open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, has acquired Crelux GmbH, a structure based drug discovery provider based in Munich, Germany.
read more